Frédéric Mathot
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 3
- Advanced Drug Delivery Systems 3
-
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- Véronique Préat A (5 shared papers)Marcus Eli Brewster (3 shared papers)Albertina Ariën (3 shared papers)Myriam Nenquin (3 shared papers)Jean‐Claude Henquin (3 shared papers)Ludy van Beijsterveldt (1 shared paper)Anne des Rieux (1 shared paper)Yves‐Jacques Schneider (1 shared paper)
- Journals
- Journal of Controlled Release (3 papers)Journal of Pharmaceutical Sciences (2 papers)Biochemical Pharmacology (1 paper)FEBS Letters (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- BelgiumGermanySwitzerland
In The Last Decade
Frédéric Mathot
10 papers receiving 363 citations
Peers
Comparison fields: 5 of 50
- Pharmaceutical Science 125
- Biomaterials 97
- Surgery 117
- Physiology 6
- Immunology 17
Countries citing papers authored by Frédéric Mathot
This map shows the geographic impact of Frédéric Mathot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Mathot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Mathot more than expected).
Fields of papers citing papers by Frédéric Mathot
This network shows the impact of papers produced by Frédéric Mathot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Mathot. The network helps show where Frédéric Mathot may publish in the future.
Co-authors
The 17 scholars most cited alongside Frédéric Mathot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 94 | |
| 2 | 2006 | 92 | |
| 3 | 2007 | 80 | |
| 4 | 1984 | 36 | |
| 5 | 1985 | 25 | |
| 6 | 2007 | 24 | |
| 7 | 2016 | 23 | |
| 8 | 2014 | 6 | |
| 9 | 2024 | 5 | |
| 10 | 2025 | 1 |
About Frédéric Mathot
Frédéric Mathot is a scholar working on Pharmaceutical Science, Biomaterials, Immunology, Surgery and Emergency Medicine, having authored 10 papers that have together received 386 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (3 papers), Advanced Drug Delivery Systems (3 papers), Pancreatic function and diabetes (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Aluminum toxicity and tolerance in plants and animals (2 papers), Immunotherapy and Immune Responses (2 papers), Lipid Membrane Structure and Behavior (1 paper) and Intramuscular injections and effects (1 paper). The work is most often cited by research in Pharmaceutical Science (125 citations), Biomaterials (97 citations), Surgery (117 citations), Physiology (6 citations) and Immunology (17 citations). Frédéric Mathot has collaborated with scholars based in Belgium, Germany and Switzerland. Frequent co-authors include Véronique Préat A, Marcus Eli Brewster, Albertina Ariën, Myriam Nenquin, Jean‐Claude Henquin, Ludy van Beijsterveldt, Anne des Rieux, Yves‐Jacques Schneider, Dominique Lemoine and Giuseppe Paolisso. Their work appears in journals such as Journal of Controlled Release, Journal of Pharmaceutical Sciences, Biochemical Pharmacology, FEBS Letters and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.